Lyell Immunopharma, Inc. (LYEL)
30.78
-0.81
(-2.56%)
USD |
NASDAQ |
Dec 31, 16:00
31.10
+0.32
(+1.04%)
Pre-Market: 09:25
Lyell Immunopharma Research and Development Expense (TTM): 140.98M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 695.91M |
| Nektar Therapeutics | 116.36M |
| GT Biopharma, Inc. | 4.026M |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| Regeneron Pharmaceuticals, Inc. | 5.097B |